These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18220510)

  • 1. Drug discovery for Alzheimer's disease: filling the pipeline.
    Horton AR; Fillit HM
    Curr Alzheimer Res; 2007 Dec; 4(5):501-2. PubMed ID: 18220510
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's disease drug discovery: Abeta and beyond.
    Shineman DW; Fillit HM
    Curr Alzheimer Res; 2010 May; 7(3):188-9. PubMed ID: 20406195
    [No Abstract]   [Full Text] [Related]  

  • 3. New Alzheimer's clinical trials to be undertaken by NIA nationwide consortium.
    Am J Alzheimers Dis Other Demen; 2006 Dec-2007 Jan; 21(6):460-1. PubMed ID: 17288014
    [No Abstract]   [Full Text] [Related]  

  • 4. Alzheimer's disease: genotypes, phenotypes, and treatments.
    Selkoe DJ
    Science; 1997 Jan; 275(5300):630-1. PubMed ID: 9019820
    [No Abstract]   [Full Text] [Related]  

  • 5. Discovery of ADDL--targeting small molecule drugs for Alzheimer's disease.
    Look GC; Jerecic J; Cherbavaz DB; Pray TR; Breach JC; Crosier WJ; Igoudin L; Hironaka CM; Lowe RM; McEntee M; Ruslim-Litrus L; Wu HM; Zhang S; Catalano SM; Goure WF; Summa D; Krafft GA
    Curr Alzheimer Res; 2007 Dec; 4(5):562-7. PubMed ID: 18220523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease--current trends in basic and clinical research. Highlights from the 16th ECNP. September 20-24 2003, Prague, Czech Republic.
    Lahiri DK
    Expert Opin Investig Drugs; 2004 Jan; 13(1):79-86. PubMed ID: 14680456
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: Next-Generation Alzheimer's Therapeutics: Leveraging Deep Biology.
    Longo FM; Massa SM
    J Prev Alzheimers Dis; 2020; 7(3):138-139. PubMed ID: 32463062
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings of the 10th International Conference on Alzheimer's Drug Discovery. September 14-15, 2009. Jersey City, New Jersey, USA.
    Curr Alzheimer Res; 2010 May; 7(3):188-279. PubMed ID: 20687240
    [No Abstract]   [Full Text] [Related]  

  • 9. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
    Haas C
    J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward an integrated discovery and development program in Alzheimer's disease: the amyloid hypothesis.
    Greenberg BD; Murphy MF
    Neurobiol Aging; 1994; 15 Suppl 2():S105-9. PubMed ID: 7700430
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicine. Old drug, new hope for Alzheimer's disease.
    Strittmatter WJ
    Science; 2012 Mar; 335(6075):1447-8. PubMed ID: 22442467
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting nascent soluble Aβ42 for potential Alzheimer drug development.
    Zhang M; Hausmann L; Song W
    J Neurochem; 2013 May; 125(3):329-31. PubMed ID: 23405973
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: Combining Forces to Improve Alzheimer's Disease Drug Discovery: The Symptomatic Battle.
    Deguil J; Auffret A; Schenker E; Aujard F; Lamberty Y; Bartrès-Faz D; Blin O; Micallef J; Richardson JC; Bordet R
    CNS Neurol Disord Drug Targets; 2016; 15(7):754-5. PubMed ID: 27549167
    [No Abstract]   [Full Text] [Related]  

  • 14. Apolipoprotein E, A beta-amyloid, and the molecular pathology of Alzheimer's disease. Therapeutic implications.
    Kaplitt M; Gouras GK; Makimura H; Jovanovic J; Sweeney D; Greengard P; Relkin NR; Gandy S
    Ann N Y Acad Sci; 1996 Dec; 802():42-9. PubMed ID: 8993483
    [No Abstract]   [Full Text] [Related]  

  • 15. [Memory mechanisms and expectancy of therapy in Alzheimer's disease].
    Vetulani J
    Neurol Neurochir Pol; 2000; 34(3):429-46. PubMed ID: 10979538
    [No Abstract]   [Full Text] [Related]  

  • 16. Preclinical success against Alzheimer's disease with an old drug.
    LaFerla FM
    N Engl J Med; 2012 Aug; 367(6):570-2. PubMed ID: 22873540
    [No Abstract]   [Full Text] [Related]  

  • 17. Apolipoprotein E and Alzheimer's disease.
    Scott J
    Lancet; 1993 Sep; 342(8873):696. PubMed ID: 8103818
    [No Abstract]   [Full Text] [Related]  

  • 18. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.
    Lim GP; Calon F; Morihara T; Yang F; Teter B; Ubeda O; Salem N; Frautschy SA; Cole GM
    J Neurosci; 2005 Mar; 25(12):3032-40. PubMed ID: 15788759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alzheimer's disease--the molecular biological mechanism and the therapeutic drug design].
    Nabeshima T; Takeda M
    Nihon Yakurigaku Zasshi; 1996 Sep; 108(3):132-4. PubMed ID: 9091440
    [No Abstract]   [Full Text] [Related]  

  • 20. Towards retinoid therapy for Alzheimer's disease.
    Shudo K; Fukasawa H; Nakagomi M; Yamagata N
    Curr Alzheimer Res; 2009 Jun; 6(3):302-11. PubMed ID: 19519313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.